AMPH Earnings Amphastar Pharmaceuticals, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–44 of 44
| Q2 2026 | 2026-06-30 | 0.81 | 2026-08-06 | 10-Q |
| Q1 2026 | 2026-03-31 | 0.14 | 2026-05-07 | 10-Q |
| FY 2025 | 2025-12-31 | 2.03 | 2026-02-26 | 10-K |
| Q3 2025 | 2025-09-30 | 1.52 | 2025-11-06 | 10-Q |
| Q2 2026 | 2025-06-30 | 1.15 | 2026-08-06 | 10-Q |
| Q1 2026 | 2025-03-31 | 0.51 | 2026-05-07 | 10-Q |
| FY 2025 | 2024-12-31 | 3.06 | 2026-02-26 | 10-K |
| Q3 2025 | 2024-09-30 | 2.32 | 2025-11-06 | 10-Q |
| Q2 2025 | 2024-06-30 | 1.54 | 2025-08-07 | 10-Q |
| Q1 2025 | 2024-03-31 | 0.81 | 2025-05-08 | 10-Q |
| FY 2025 | 2023-12-31 | 2.60 | 2026-02-26 | 10-K |
| Q3 2024 | 2023-09-30 | 1.91 | 2024-11-07 | 10-Q |
| Q2 2024 | 2023-06-30 | 0.99 | 2024-08-09 | 10-Q |
| Q1 2024 | 2023-03-31 | 0.50 | 2024-05-10 | 10-Q |
| FY 2024 | 2022-12-31 | 1.74 | 2025-03-03 | 10-K |
| Q3 2023 | 2022-09-30 | 1.09 | 2023-11-08 | 10-Q |
| Q2 2023 | 2022-06-30 | 0.79 | 2023-08-09 | 10-Q |
| Q1 2023 | 2022-03-31 | 0.47 | 2023-05-09 | 10-Q |
| FY 2023 | 2021-12-31 | 1.25 | 2024-02-29 | 10-K |
| Q3 2022 | 2021-09-30 | 0.85 | 2022-11-08 | 10-Q |
| Q2 2022 | 2021-06-30 | 0.26 | 2022-08-09 | 10-Q |
| Q1 2022 | 2021-03-31 | 0.10 | 2022-05-10 | 10-Q |
| FY 2022 | 2020-12-31 | 0.03 | 2023-03-01 | 10-K |
| Q3 2021 | 2020-09-30 | 0.16 | 2021-11-09 | 10-Q |
| Q2 2021 | 2020-06-30 | 0.08 | 2021-08-09 | 10-Q |
| Q1 2021 | 2020-03-31 | 0.08 | 2021-05-07 | 10-Q |
| FY 2021 | 2019-12-31 | 0.98 | 2022-03-11 | 10-K |
| Q3 2020 | 2019-09-30 | 1.00 | 2020-11-06 | 10-Q |
| Q2 2020 | 2019-06-30 | 0.97 | 2020-08-07 | 10-Q |
| Q1 2020 | 2019-03-31 | 0.02 | 2020-05-11 | 10-Q |
| FY 2020 | 2018-12-31 | -0.12 | 2021-03-15 | 10-K |
| FY 2019 | 2018-09-30 | 0.05 | 2020-03-16 | 10-K |
| FY 2019 | 2018-06-30 | -0.06 | 2020-03-16 | 10-K |
| FY 2019 | 2018-03-31 | -0.15 | 2020-03-16 | 10-K |
| FY 2019 | 2017-12-31 | 0.08 | 2020-03-16 | 10-K |
| FY 2018 | 2017-09-30 | 0.00 | 2019-03-15 | 10-K |
| FY 2018 | 2017-06-30 | 0.04 | 2019-03-15 | 10-K |
| FY 2018 | 2017-03-31 | 0.02 | 2019-03-15 | 10-K |
| FY 2018 | 2016-12-31 | 0.21 | 2019-03-15 | 10-K |
| FY 2017 | 2016-09-30 | 0.08 | 2018-03-14 | 10-K |
| FY 2017 | 2016-06-30 | 0.15 | 2018-03-14 | 10-K |
| FY 2017 | 2016-03-31 | 0.05 | 2018-03-14 | 10-K |
| FY 2017 | 2015-12-31 | -0.06 | 2018-03-14 | 10-K |
| FY 2016 | 2015-09-30 | -0.07 | 2017-03-15 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.